Bone Marrow TransplantationTissue DonorsTransplantation, HomologousHistocompatibility TestingGraft vs Host DiseaseHistocompatibilityBone MarrowGraft SurvivalBone Marrow CellsTransplantation ChimeraWhole-Body IrradiationTransplantation, AutologousTransplantation ConditioningSurvival AnalysisAnemia, AplasticLeukemiaHematopoietic Stem Cell TransplantationBone and BonesGraft RejectionTransplantation, IsogeneicLiver TransplantationRadiation ChimeraGraft Enhancement, ImmunologicTransplantation ToleranceHematopoietic Stem CellsKidney TransplantationLeukocyte TransfusionImmunosuppressive AgentsMice, Inbred C57BLBusulfanBone Marrow PurgingSkin TransplantationRecurrenceImmunosuppressionHLA AntigensTransplantation ImmunologyLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionChimerismTreatment OutcomeHeart TransplantationActuarial AnalysisPrecursor Cell Lymphoblastic Leukemia-LymphomaCyclophosphamideTime FactorsBone Marrow DiseasesT-LymphocytesHematopoiesisAcute DiseaseCombined Modality TherapyLeukemia, Myeloid, AcuteBone Marrow ExaminationLymphocyte Culture Test, MixedHematologic NeoplasmsRemission InductionChimeraHepatic Veno-Occlusive DiseaseBone RemodelingBone Marrow NeoplasmsGraft vs Host ReactionLiving DonorsMice, Inbred BALB CLeukemia, MyeloidStem Cell TransplantationLymphoma, Non-HodgkinLymphocyte TransfusionDisease-Free SurvivalSevere Combined ImmunodeficiencyColony-Forming Units AssayRetrospective StudiesMyelodysplastic SyndromesLung TransplantationCyclosporineHematologic DiseasesBlood DonorsBone DensityMice, Inbred C3HImmune ToleranceOrgan TransplantationNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsCarmustineGraft vs Tumor EffectFlow CytometryCell DifferentiationPancytopeniaFollow-Up StudiesSurvival RateCytomegalovirus InfectionsLeukocyte CountGraft vs Leukemia EffectCytarabineSpleenGranulocyte Colony-Stimulating FactorBone ResorptionMelphalanEtoposideLymphomaMultiple MyelomaCells, Cultured